New class of glutamate agonist structurally related to ibotenic acid.
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D001667:Binding, Competitive; D001921:Brain / Q000187:drug effects; D005971:Glutamates / Q000494:pharmacology*; D007051:Ibotenic Acid / Q000031:analogs & derivatives / Q000494:pharmacology*; D066298:In Vitro Techniques; D007608:Kainic Acid / Q000037:antagonists & inhibitors / Q000378:metabolism; D018377:Neurotransmitter Agents / Q000494:pharmacology*; D010080:Oxazoles / Q000494:pharmacology*; D051381:Rats; D013131:Spine / Q000187:drug effects; D013329:Structure-Activity Relationship; D013570:Synaptic Membranes / Q000378:metabolism
D005971:Glutamates; D018377:Neurotransmitter Agents; D010080:Oxazoles; D007051:Ibotenic Acid; C023362:alpha-amino-3-(hydroxy)-5-methyl-4-isoxazoleacetic acid; D007608:Kainic Acid